Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent Influenza Split Vaccine Phase I/III Trial
CTR20160152Phase 3Active
- Sponsor
- Changchun Changsheng Biotechnology
- Start
- Mar 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of quadrivalent inactivated split influenza vaccine in influenza, sponsored by Changchun Changsheng Biotechnology. Started Mar 2016; status: active.
02
Drugs
quadrivalent inactivated split influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20160152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160152.